High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study.

Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes: A Randomized Controlled Trial

Nissen, S. E., Tsunoda, T., Tuzcu, E. M., Schoenhagen, P., Cooper, C. J., Yasin, M., Eaton, G. M., Lauer, M. A., Sheldon, W. S., Grines, C. L., et al. (2003) · JAMA · doi:10.1001/jama.290.17.2292 · Cited by 1,707

AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES

Kannel, W. B., Feinleib, M., McNAMARA, P. M., Garrison, R. J., & Castelli, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,639

Molecular physiology of reverse cholesterol transport.

Fielding, C. J., & Fielding, P. E. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39898-9 · Cited by 1,448

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

Stampfer, M. J., Sacks, F. M., Salvini, S., Willett, W. C., & Hennekens, C. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108083250601 · Cited by 1,163

The Framingham Offspring Study

Allhoff, P., Laaser, U., & Heinrich, J. (1991) · Springer eBooks · doi:10.1007/978-3-642-95642-3_25 · Cited by 832

Early incorporation of cell-derived cholesterol into pre-.beta.-migrating high-density lipoprotein

Castro, G. R., & Fielding, C. J. (1988) · Biochemistry · doi:10.1021/bi00401a005 · Cited by 641

Autoradiography using storage phosphor technology

Johnston, R. F., Pickett, S. C., & Barker, D. L. A. (1990) · Electrophoresis · doi:10.1002/elps.1150110503 · Cited by 525

Apolipoprotein A-I containing lipoproteins in coronary artery disease

Puchois, P., Kandoussi, A., Fievet, P., Fourrier, J. L., Bertrand, M. E., Koren, E., & Fruchart, J. (1987) · Atherosclerosis · doi:10.1016/0021-9150(87)90091-8 · Cited by 326

Two-dimensional electrophoresis of plasma lipoproteins: Recognition of new apo A-I-containing subpopulations

Asztalos, B. F., Sloop, C. H., Wong, L., & Roheim, P. S. (1993) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(93)90253-6 · Cited by 235

A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study.

Parra, H. J., Arveiler, D., Evans, A. E., Cambou, J., Amouyel, P., Bingham, A., McMaster, D., Schaffer, P., DOUSTE‐BLAZY, P., & Luc, G. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.6.701 · Cited by 232

Ruminant-Produced trans-Fatty Acids Raise Plasma HDL Particle Concentrations in Intact and Ovariectomized Female Hartley Guinea Pigs

Rice, B. H., Kraft, J., Destaillats, F., Bauman, D. E., & Lock, A. L. (2012) · Journal of Nutrition · doi:10.3945/jn.112.160077 · Cited by 11

High-density lipoprotein: our elusive friend

Asztalos, B. F., Niisuke, K., & Horvath, K. V. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000612 · Cited by 11

Reduced high-density lipoprotein 2b in non-obese type 2 diabetic patients analysed by a microfluidic chip method in a case–control study

Xian, X., Ma, Y., Yang, D.-H. D., Huang, W. Y., Wang, Y., Mueller, O., Chang, E., Konigshofer, Y., Van-Cleve, M., Yang, J., et al. (2009) · Biomarkers · doi:10.3109/13547500903204636 · Cited by 11

Is HDL a prognostic biomarker for coronary atherosclerosis?

Παπαγεωργίου, Ν., & Tousoulis, D. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.04.227 · Cited by 11

Human HDL subclasses modulate energy metabolism in skeletal muscle cells

Lund, J., Lähteenmäki, E. I., Eklund, T., Bakke, H. G., Thoresen, G. H., Pirinen, E., Jauhiainen, M., Rustan, A. C., & Lehti, M. (2023) · Journal of Lipid Research · doi:10.1016/j.jlr.2023.100481 · Cited by 10

Body Mass Index and Cardiovascular Risk Markers: A Large Population Analysis

Asztalos, B. F., Russo, G. T., He, L., & Diffenderfer, M. R. (2025) · Nutrients · doi:10.3390/nu17050740 · Cited by 10

Total HDL cholesterol efflux capacity in healthy children – Associations with adiposity and dietary intakes of mother and child

Khalil, H. S., Murrin, C. M., O'Reilly, M. E., Viljoen, K., Segurado, R., O’Brien, J., Somerville, R. L., McGillicuddy, F. C., & Kelleher, C. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.10.002 · Cited by 10

Elevated levels of preβ1-high-density lipoprotein are associated with cholesterol ester transfer protein, the presence and severity of coronary artery disease

Bu, X., Niu, D.-M., Wu, J., Yuan, Y., Song, J., & Wang, J. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-016-0394-1 · Cited by 10

Cardiovascular Risk Factor Reduction in First Responders Resulting From an Individualized Lifestyle and Blood Test Program

Gill, R. D., Superko, H. R., McCarthy, M. M., Jack, K., Jones, B., Ghosh, D., Richards, S., Gleason, J. A., Williams, P. T., & Dansinger, M. L. (2018) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000001490 · Cited by 10

Lipoprotein Subclasses Independently Contribute to Subclinical Variance of Microvascular and Macrovascular Health

Streese, L., Habisch, H., Deiseroth, A., Carrard, J., Infanger, D., Schmidt‐Trucksäss, A., Madl, T., & Hanssen, H. (2022) · Molecules · doi:10.3390/molecules27154760 · Cited by 10

The relationship between physical activity and lipoprotein subclasses in postmenopausal women

Gabriel, K. P., Kriska, A. M., Johnson, B. D., Conroy, M. B., Mackey, R. H., Orchard, T. J., & Kuller, L. H. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000229573.29258.d5 · Cited by 10

Xanthophylls, Phytosterols and Pre‐β1‐HDL are Differentially Affected by Fenofibrate and Niacin HDL‐Raising in a Cross‐Over Study

Niesor, E. J., Gauthamadasa, K., Silva, R. A. G. D., Suchánková, G., Kallend, D. G., Gylling, H., Asztalos, B. F., Damonte, E., Rossomanno, S., Abt, M., et al. (2013) · Lipids · doi:10.1007/s11745-013-3841-z · Cited by 10

High-density lipoprotein infusion therapy: A review

Brewer, H. B., Schaefer, E. J., Foldyna, B., & Ghoshhajra, B. B. (2024) · Journal of clinical lipidology · doi:10.1016/j.jacl.2024.01.009 · Cited by 9

High-Density Lipoprotein Particles, Inflammation, and Coronary Heart Disease Risk

Stock, E. O., Asztalos, B. F., Miller, J. M., He, L., Creasy, K. T., Schwemberger, R., Quinn, A. T., Pullinger, C. R., Malloy, M. J., Diffenderfer, M. R., et al. (2025) · Nutrients · doi:10.3390/nu17071182 · Cited by 9

Case report: A novel apolipoprotein A-I missense mutation apoA-I (Arg149Ser)Boston associated with decreased lecithin-cholesterol acyltransferase activation and cellular cholesterol efflux

Anthanont, P., Asztalos, B. F., Polisecki, E. Y., Zachariah, B., & Schaefer, E. J. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.02.005 · Cited by 8

Crosstalk between high-density lipoproteins and endothelial cells in health and disease: Insights into sex-dependent modulation

Dietrich, E., Jomard, A., & Osto, E. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.989428 · Cited by 9

Preβ1-high-density lipoprotein metabolism is delayed in patients with chronic kidney disease not on hemodialysis

Yamatani, K., Hirayama, S., Seino, U., Hirayama, A., Hori, A., Suzuki, K., Idei, M., Kitahara, M., & Miida, T. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.07.011 · Cited by 8

Denaturation of human plasma high-density lipoproteins by urea studied by apolipoprotein A-I dissociation

Dergunov, A. D., Litvinov, D. Y., Malkov, A. A., Baserova, V. B., Nosova, E. V., & Dergunova, L. V. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158814 · Cited by 7

Pre-β-HDL formation relates to high-normal free thyroxine in type 2 diabetes mellitus

van Tienhoven‐Wind, L. J. N., Perton, F. G., & Dullaart, R. P. F. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.08.024 · Cited by 8

Combining Rosuvastatin With Angiotensin-Receptor Blockers of Different PPARγ-Activating Capacity

Rizos, C. V., Liberopoulos, E. N., Tellis, K., DiNicolantonio, J. J., Tselepis, A. D., & Elisaf, M. (2013) · Angiology · doi:10.1177/0003319713512556 · Cited by 8

High-density lipoprotein: what is the best way to measure its antiatherogenic potential?

Remaley, A. T., & Warnick, G. R. (2008) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2.7.773 · Cited by 8

Effects of heavy alcohol intake on lipoproteins, adiponectin and cardiovascular risk

Kuusisto, S. M. (2014) · Cited by 7

Where next with HDL assays?

Niisuke, K., Horvath, K. V., & Asztalos, B. F. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000529 · Cited by 7

Relation of High‐Density Lipoprotein Charge Heterogeneity, Cholesterol Efflux Capacity, and the Expression of High‐Density Lipoprotein‐Related Genes in Mononuclear Cells to the HDL‐Cholesterol Level

Dergunov, A. D., Litvinov, D. Y., Bazaeva, E. V., Dmitrieva, V. G., Nosova, E. V., Rozhkova, A. V., & Dergunova, L. V. (2018) · Lipids · doi:10.1002/lipd.12104 · Cited by 7

Statin Treatment Improves Plasma Lipid Levels but not HDL Subclass Distribution in Patients Undergoing Percutaneous Coronary Intervention

Tian, L., Chen, Y., Li, C., Zeng, Z., Xu, Y., Long, S., & Fu, M. (2012) · Lipids · doi:10.1007/s11745-012-3750-6 · Cited by 7

The Effect of apoM Polymorphism Associated with HDL Metabolism on Obese Korean Adults

Lee, M., Kim, J.-I., Choi, S., Jang, Y., & Sorn, S. R. (2016) · Lifestyle Genomics · doi:10.1159/000455948 · Cited by 7

Rural–urban differences in lipid abnormalities among middle-aged and older Indians

Chatterjee, P. B., Arora, S., Rai, P., Diwakar, L., Issac, T. G., & Sundarakumar, J. S. (2025) · BMC Public Health · doi:10.1186/s12889-025-22625-3 · Cited by 6

In vivo triglyceride synthesis in subcutaneous adipose tissue of humans correlates with plasma HDL parameters

Tuvdendorj, D., Munoz, A., Ruiz-Barros, V., Schwarz, J., Montalto, G., Chandalia, M., Sowers, L. C., Rizzo, M., Murphy, E. J., & Abate, N. I. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.06.024 · Cited by 6

PCSK9 is minimally associated with HDL but impairs the anti-atherosclerotic HDL effects on endothelial cell activation

Dafnis, I., Tsouka, A. N., Gkolfinopoulou, C., Tellis, C. C., Chroni, A., & Tselepis, A. D. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100272 · Cited by 7

Lipoproteins and lipoprotein lipid composition are associated with stages of dysglycemia and subclinical coronary atherosclerosis

Gigante, B., Chen, Q., Björkbacka, H., Björnson, E., Brinck, J. W., Chorell, E., Djekic, D., Edsfeldt, A., Engström, G., Eriksson, J. W., et al. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132698 · Cited by 6

Biomarkers and Sustainable Innovation in Cardiovascular Drug Development: Lessons from Near and Far Afield

Medford, R. M., Dagi, T. F., Rosenson, R. S., & Offermann, M. K. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0321-0 · Cited by 6

The Association of Passive Smoking and Dyslipidemia Among Adolescence in Japan: Results From A-CHILD Study

Miyamura, K., Nawa, N., Isumi, A., Doi, S. K., Ochi, M., & Fujiwara, T. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab094 · Cited by 6

The Role of Advanced Lipid Testing in Clinical Practice

Karalis, D. G. (2007) · Preventive Cardiology · doi:10.1111/j.1520-037x.2007.07333.x · Cited by 6

High density lipoprotein particle size and function associate with new cardiovascular events in patients with chronic kidney disease

Mathew, A. V., Han, Y. J., Cheofor, V. K., Guo, Y., Byun, J., George, A., Meza, J., Rajagopalan, S., Chen, Y. E., Gillespie, B. W., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0320803 · Cited by 5

Identification of genetic drivers of plasma lipoprotein size in the Diversity Outbred mouse population

Price, T. R., Emfinger, C. H., Schueler, K. L., King, S. M., Nicholson, R. J., Beck, T., Yandell, B. S., Summers, S. A., Holland, W. L., Krauss, R. M., et al. (2023) · Journal of Lipid Research · doi:10.1016/j.jlr.2023.100471 · Cited by 5

Relationship between the distribution of plasma HDL subclasses and the polymorphisms of APOA5 in hypertriglyceridemia

Long, S., Chen, Z., Han, Y., Christopher, D. M., Zhang, C., Yang, Y., & Tian, Y. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.03.003 · Cited by 5

High-Density Lipoproteins

Toth, P. P. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-533-6_9 · Cited by 5

Physical Activity, Exercise, and Lipids and Lipoproteins

Durstine, J. L., Anderson, E., Porter, R. R., & Wang, X. (2019) · Springer eBooks · doi:10.1007/978-3-030-04816-7_16 · Cited by 5

Pleiotropic Functions of HDL Lead to Protection from Atherosclerosis and Other Diseases

Zannis, V. I., Kateifides, A. K., Fotakis, P., Zanni, E. E., & Kardassis, D. (2012) · InTech eBooks · doi:10.5772/30054 · Cited by 5

HDL subfractions determined by microfluidic chip electrophoresis predict the vulnerability of intracranial plaque: A HRMRI study

Zhezhi, D., Zhihui, Z., Shifeng, Z., Minping, L., Xue, X., Weiwei, Q., Junjie, G., Zhou, D., Ma, Q., Qiu, Y., et al. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117713 · Cited by 4

A case-control study on the relationship between HDL2b and non-alcoholic fatty liver disease in Chinese type 2 diabetic patients

Ma, Y.-H., Zhao, L., Xian, X., Yang, D. D., Huang, W. Y., Wang, Y.-H., Mueller, O., Chang, E., Konigshofer, Y., Van-Cleve, M., et al. (2009) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2009.257 · Cited by 4

Association of lipoprotein subfractions with endothelial function and arterial stiffness in acute ischemic stroke

Šiarnik, P., Čarnická, Z., Krivošíková, Z., Klobučníková, K., Žitňanová, I., Kollár, B., Sykora, M., & Turčáni, P. (2016) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2016.1243257 · Cited by 4

Oxidized high-density lipoprotein reduces blood clot firmness

Talens, S., Malfliet, J. J. M. C., Leebeek, F. W. G., & Rijken, D. C. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12125 · Cited by 4

Emerging Therapies for Residual Risk

Mehra, S., Movahed, H., & Movahed, A. (2012) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0583 · Cited by 3

Trastornos motores y funcionales del esófago

Soto-Pérez, J. C. (2012) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2012.07.017 · Cited by 3

Lipoprotein Abnormalities in Patients with Atherosclerotic Renovascular Disease

Nowakowska-Fortuna, E., Herlitz, H., Saeed, A., Attman, P., Jensen, G., Alaupovic, P., & Guron, G. (2011) · Kidney & Blood Pressure Research · doi:10.1159/000325648 · Cited by 3

Changes in the size and electrophoretic mobility of HDL subpopulation particles in chronic kidney disease

Gliwińska, A., Ćwiklińska, A., Czaplińska, M., Wieczorek, E., Kortas‐Stempak, B., Kuchta, A., Dębska-Ślizień, A. M., Król, E., & Jankowski, M. (2022) · Journal of Nephrology · doi:10.1007/s40620-022-01412-y · Cited by 3

Dysfunctional HDL Diagnostic Metrics for Cardiovascular Disease Risk Stratification: Are we Ready to Implement in Clinics?

Kempegowda, S. N., Sugur, K., & Thimmulappa, R. K. (2024) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-024-10559-x · Cited by 3

The influence of plasma apolipoprotein A‐II concentrations on HDL subclass distribution

Tian, L., Wu, X., Fu, M., Xu, Y., & Jia, L. (2008) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.200700281 · Cited by 3

Lipid‐Modulating Treatments for Mixed Dyslipidemia Increase HDL‐Associated Phospholipase A2 Activity with Differential Effects on HDL Subfractions

Kei, A. A., Liberopoulos, E. N., Tellis, C. C., Elisaf, M., & Tselepis, A. D. (2013) · Lipids · doi:10.1007/s11745-013-3826-y · Cited by 3

Gender and age differences in the distribution of the HDL subclasses among the Chinese population

Tian, L., Yang, Y., Fu, M., & Xu, Y. (2010) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.200900040 · Cited by 3

Primary care physician treatment of low HDL: Rational approach or Pandora’s Box?

Deeg, M. A., Jacob, S., Shen, J., & Marrero, D. G. (2007) · Journal of clinical lipidology · doi:10.1016/j.jacl.2007.04.002 · Cited by 3

Lipoprotein subclasses compensate the classic atherogenic lipid profile of women with polycystic ovary syndrome, but common antiandrogenic treatments worsen their lipidome

Luque‐Ramírez, M., Martínez-García, M. Á., Insenser, M. R., Quintero-Tobar, A., Quiñones, S. D. L., Nattero‐Chávez, L., & Escobar-Morreale, H. F. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf213 · Cited by 2

HDL subpopulations: Of mice and men

Eck, M. V. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.12.018 · Cited by 2

Evaluación de la heterogeneidad y función de HDL por el laboratorio

Movva, R., & Rader, D. J. (2009) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 2

[High and low density lipoprotein abnormalities in coronary patients with LDL-C at target and uncontrolled HDL-C and triglycerides].

Posadas‐Romero, C., Posadas‐Sánchez, R., Juárez-Rojas, J. G., Medina-Urrutia, A. X., Galarza, E. J., Cardoso-Saldaña, G. C., Caracas-Portilla, N., & Mendoza-Peŕez, E. (2008) · PubMed · Cited by 2

HDL function and cardiovascular risk: Debate continues…

Stock, J. K. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.04.032 · Cited by 2

El ácido nicotínico aumenta el transporte celular de colesterol de las lipoproteínas de alta densidad en pacientes con hipoalfalipoproteinemia

Figueroa, C., Droppelmann, K., Quiñones, V., Amigo, L., Mendoza, C., Serrano, V., Véjar, M., Alberto Maiz, G., & Rigotti, A. (2015) · Revista médica de Chile · doi:10.4067/s0034-98872015000900001 · Cited by 2

Lessons from Experimental-Induced Atherosclerosis: Valuable for the Precision Medicine of Tomorrow

Călin, M., Butoi, E. D., Manea, S., Simionescu, M., & Manea, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-34193-4_17 · Cited by 2

Nutritional Factors and High‐Density Lipoprotein Metabolism

Schaefer, E. J., Lamon‐Fava, S., & Asztalos, B. F. (2007) · Wiley eBooks · doi:10.1002/9783527625178.ch17 · Cited by 2

Chromatography of Membrane Proteins and Lipoproteins

Zolla, L., & D’Alessandro, A. (2011) · Encyclopedia of Analytical Chemistry · doi:10.1002/9780470027318.a1607.pub2 · Cited by 2

Introduction of HDL Molecules, Past and Brief Future

Tabuchi, M., & Komoda, T. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-407867-3.00001-9 · Cited by 1

A case–control study on reduced HDL2b in patients with polycystic ovarian syndrome

Hu, W., Chen, L., Mao, S., & Qiao, J. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1182151 · Cited by 1

Preβ1-HDL, a Native Lipid-poor HDL, and its Potential as a New Marker for HDL Metabolism

Miida, T., & Hirayama, S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-382171-3.10012-9 · Cited by 1

Analysis of TEM micrographs with deep learning reveals APOE genotype-specific associations between HDL particle diameter and Alzheimer’s dementia

Zheng, J. J., Hong, B. V., Agus, J., Tang, X., Guo, F., Lebrilla, C. B., Maezawa, I., Jin, L., Vreeland, W. N., Ripple, D. C., et al. (2025) · Cell Reports Methods · doi:10.1016/j.crmeth.2024.100962 · Cited by 1

Serum Paraoxonase (PON1) and its Interactions with HDL

Vekić, J., Kotur‐Stevuljević, J., Zeljković, A., Stefanović, A., Jelić‐Ivanović, Z., Spasić, S., & Spasojević‐Kalimanovska, V. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-382171-3.10005-1 · Cited by 1

Newer Therapeutic Strategies to Alter High-Density Lipoprotein Level and Function

Bosch, N. A., & Frishman, W. H. (2013) · Cardiology in Review · doi:10.1097/crd.0b013e31829cac29 · Cited by 1

Native High-Density Lipoprotein and Melatonin Improve Platelet Response Induced by Glycated Lipoproteins

Özsavcı, D., Nazli, A., Özakpınar, Ö. B., Demirel, G. Y., Kural, B. V., & Şener, A. (2018) · Folia Biologica · doi:10.14712/fb2018064040144 · Cited by 1

Association of Lipid Profile with Sleep-Disordered Breathing in Patients with Acute Ischemic Stroke

Šiarnik, P., Kollár, B., Filippi, P., Klobučníková, K., Hlucháňová, A., Žitňanová, I., & Turčáni, P. (2020) · Journal of Stroke Medicine · doi:10.1177/2516608520919211 · Cited by 1

High Density Lipoproteins, Dyslipidemia, and Heart Disease: Past, Present, and Future

Schaefer, E. J., & Santos, R. D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1059-2_23 · Cited by 1

Efeito dos ácidos graxos ômega-3, ômega-6 e ômega-9 sobre o risco cardiovascular de indivíduos adultos: estudo clínico de prevenção primária.

Pappiani, C. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.6.2016.tde-02062016-145648 · Cited by 1

Heterogeneity

Kontush, A., & Chapman, M. J. (2011) · doi:10.1002/9781118158678.ch2 · Cited by 1

Impact of glycaemic index of high carbohydrate diets on exercise energy metabolism and capacity and fasting concentration of plasma lipids in healthy physically active individuals

Hamzah, S. H. (2011) · Enlighten: Theses (The University of Glasgow)

Effects of corticosteroid treatment on high-density lipoprotein distribution and function

Cakan, Y. (2014) · The Sydney eScholarship Repository (The University of Sydney)

Investigation of total HDL and HDL subclass kinetics using stable isotope techniques in healthy subjects

Wang, K. (2015) · Surrey Research Insight Open Access (The University of Surrey)

Should we target HDL-cholesterol to reduce coronary heart disease risk?

Schaefer, E. J., & Asztalos, B. F. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0224

Influência do exercício físico nas lipoproteínas e no endotélio de pacientes com síndrome metabólica

Filho, A. C. (2007) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2007.tde-10122007-215922

Th-W50:5 One third of the variability in HDL-cholesterol level in a large dyslipidemic population is predicted by age, sex and triglyceridemia

Hansel, B., Kontush, A., Giral, P., Bonnefont, D., Chapman, M., & Bruckert, É. (2006) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(06)81876-3

HDL, Reverse Cholesterol Transport, and Atherosclerosis

Franceschini, G., Gomaraschi, M., & Calabresi, L. (2011) · Wiley eBooks · doi:10.1002/9781444318456.ch20

Treinamento físico aeróbio aumenta a capacidade antioxidante das HDL e reduz o estresse oxidativo plasmático no diabete melito tipo 2

Iborra, R. T. (2006) · doi:10.11606/d.5.2006.tde-06022007-150120

Differentielle Analyse des HDL-Proteoms mittels Massenspektrometrie

Zellbiologie, M., & Beisiegel†, U. (2010)

Different methods for particle diameter determination of low density and high density lipoproteins-Comparison and evaluation

Vaidyanathan, V. (2009) · OakTrust (Texas A&M University Libraries)

Efeito do ácido graxo ômega 3 sobre a composição corporal, controle glicêmico e risco cardiovascular de indivíduos adultos e idosos

Cartolano, F. D. C. (2016) · doi:10.11606/d.6.2016.tde-14122015-123925

Optical Properties of Europium Tetracycline Complexes in the Presence of High-Density Lipoproteins (HDL) Subfractions

Sicchieri, L. B., Monteiro, A. M., Neto, A. M. F., Gomes, L., & Courrol, L. C. (2016) · Applied Spectroscopy · doi:10.1177/0003702816683685

The efficacy of Nopales (Opuntia Spp) on Lipoprotein Profile and Oxidative Stress among Moderately Hypercholesterolemic Adults

Pignotti, P., & Giselle, A. (2013)

Desenvolvimento de um escore de funcionalidade da lipoproteína de alta densidade (HDL) e sua associação com algoritmos de predição de risco cardiovascular e aterosclerose subclínica em indivíduos brasileiros

de Freitas, M. C. P. (2019) · doi:10.11606/t.6.2019.tde-13082019-154054

Multiple actions of high-density lipoprotein

Florentin, M., Liberopoulos, E. N., Wierzbicki, A. S., & Mikhailidis, D. P. (2008) · Current Opinion in Internal Medicine · doi:10.1097/mci.0b013e32831550d9

Aktueller Stellenwert der HDL-Cholesterin-Bestimmung für die kardiovaskuläre Risikoabschätzung

Annema, W. (2021) · Praxis · doi:10.1024/1661-8157/a003677

Epidemiology

Kontush, A., & Chapman, M. J. (2011) · Wiley eBooks · doi:10.1002/9781118158678.ch5

Chromatography of Membrane Proteins and Lipoproteins

Zolla, L., D’Alessandro, A., & Lana, A. (2016) · Encyclopedia of Analytical Chemistry · doi:10.1002/9780470027318.a1607.pub3

Abnormal Metabolism

Kontush, A., & Chapman, M. J. (2011) · doi:10.1002/9781118158678.ch9

Repercussões do polimorfismo -250G/A da lipase hepática sobre o metabolismo das lipoproteínas plasmáticas e a aterosclerose carotídea em amostra populacional brasileira normolipidêmica e assintomática

Vieira, I. C. (2015) · doi:10.47749/t/unicamp.2015.948910

Effects of Cholesterol Ester Transfer Protein Inhibition on HDL Metabolism

Schaefer, E. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1059-2_21

Identification of genetic drivers of plasma lipoproteins in the Diversity Outbred mouse populationPreprint

Price, T. R., Emfinger, C. H., Schueler, K. L., King, S. M., Nicholson, R. J., Beck, T., Yandell, B. S., Summers, S. A., Holland, W. L., Krauss, R. M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.26.554969

Plasma Levels of Small HDL Particles Are Associated With Coronary Atherosclerosis Progression in Adults With Diabetes

Teles, B. S. B. D. S., Ramalho, S. H. R., Bittencourt, M. S., Benseñor, I. M., Blaha, M. J., Toth, P. P., Jones, S. R., Santos, R. D., Lotufo, P. A., & de Carvalho, L. S. F. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf215

THE ROLE OF PHYSICAL ACTIVITY ON CARDIOVASCULAR DISEASE RISK FACTORS IN POSTMENOPAUSAL WOMEN

Pettee, K. K. (2006) · D-Scholarship@Pitt (University of Pittsburgh)

A study of fish consumption and cardiometabolic risk factors among the circumpolar population of the rural Nenets Autonomous Area in comparison with the urban population of Arkhangelsk County

Petrenya, N. (2012) · NORA - Norwegian Open Research Archives

Etude des effets de la glycation sur les interactions protéine-ligand dans le cadre du diabète et de l’athérosclérose : la liaison entre l’albumine et le liraglutide et entre l’apolipoprotéine A1 et ses partenaires de liaison

Soudahome, A. G. (2018) · theses.fr (ABES) · doi:10.70675/a8e7886czf1afz4beeza647z45aafd3f6103

Protein-Defined Subspecies of HDLs (High-Density Lipoproteins) and Differential Risk of Coronary Heart Disease in 4 Prospective Studies

Sacks, F. M., Liang, L., Furtado, J. D., Cai, T., Davidson, W. S., He, Z., McClelland, R. L., Rimm, E. B., & Jensen, M. K. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314609 · Cited by 57

Distribution of ApoA-I–Containing HDL Subpopulations in Patients With Coronary Heart Disease

Asztalos, B. F., Roheim, P. S., Milani, R. V., LeFevre, M. L., McNamara, J. R., Horvath, K. V., & Schaefer, E. J. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.12.2670 · Cited by 193

Normolipidemic Subjects With Low HDL Cholesterol Levels Have Altered HDL Subpopulations

Asztalos, B. F., LeFevre, M. L., Foster, T. A., Tulley, R. T., WINDHAUSER, M. M., Wong, L., & Roheim, P. S. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.10.1885 · Cited by 37

Association of high-density lipoprotein subclasses and incident coronary heart disease: The Jackson Heart and Framingham Offspring Cohort Studies

Joshi, P. H., Toth, P. P., Lirette, S. T., Griswold, M. E., Massaro, J. M., Martin, S. S., Blaha, M. J., Kulkarni, K. R., Khokhar, A. A., Correa, A., et al. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487314543890 · Cited by 91

HDL subspecies : association with low HDL-C, obesity, and metabolic syndrome

Söderlund, S. (2011) · Työväentutkimus Vuosikirja